Please Wait a Moment
X

Articles

14Jun

Discontinue HIV-1 IFA Confirmatory Test

14 Jun, 2019 | Return|

CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.

Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications

Related

Reminder- Check flights and cargo hours for the Christmas Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

FDA Guidance ZIKV Testing Strategy Webinar

On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...

Read More >

CTS implements Ultrio Plus on the Panther

In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...

Read More >

Reminder-Revised Client Forms

 Just a reminder that the revised client forms implement today! Don't forget to toss your o...

Read More >

National Blood Donor Month

Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...

Read More >

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >